VEGF Production Is Regulated by the AKT/ERK1/2 Signaling Pathway and Controls the Proliferation of Toxoplasma gondii in ARPE-19 Cells
The retina is the primary site of Toxoplasma gondii infection in the eye, and choroidal neovascularization in ocular toxoplasmosis is one of the most important causes of visual impairment. Vascular endothelial growth factor (VEGF) is one of the key regulators of blood vessel development, however, li...
Gespeichert in:
Veröffentlicht in: | Frontiers in cellular and infection microbiology 2020-04, Vol.10, p.184-184, Article 184 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 184 |
---|---|
container_issue | |
container_start_page | 184 |
container_title | Frontiers in cellular and infection microbiology |
container_volume | 10 |
creator | Quan, Juan-Hua Ismail, Hassan Ahmed Hassan Ahmed Cha, Guang-Ho Jo, Young-Joon Gao, Fei Fei Choi, In-Wook Chu, Jia-Qi Yuk, Jae-Min Lee, Young-Ha |
description | The retina is the primary site of Toxoplasma gondii infection in the eye, and choroidal neovascularization in ocular toxoplasmosis is one of the most important causes of visual impairment. Vascular endothelial growth factor (VEGF) is one of the key regulators of blood vessel development, however, little is known about the mechanisms of T. gondii-induced VEGF production in ocular toxoplasmosis. Here, we investigate the effect of T. gondii on VEGF production regulation in human retinal pigment epithelium ARPE-19 cells and attempted to unveil the underlying mechanism of this event by focusing on the interaction between parasite and the selected host intracellular signaling pathways. T. gondii infection increased the expression of VEGF mRNA and protein in ARPE-19 cells in parasite burden- and infection time-dependent manner. The proportional increase of VEGF upstream regulators, HIF-1 alpha and HO-1, was also observed. T. gondii induced the activation of host p-AKT, p-ERK1/2, and p-p38 MAPK in ARPE-19 cells in a parasite-burden dependent manner. However, VEGF expression decreased after the pre-treatment with PI3K inhibitors (LY294002 and GDC-0941), ERK1/2 inhibitor (PD098059), and p38 MAPK inhibitor (SB203580), but not JNK inhibitor (SP600125), in a dose-dependent manner. The anti-VEGF agent bevacizumab or VEGF siRNA transfection prominently inhibited the activation of p-AKT and p-ERK1/2, but not p-p38 MAPK and JNK1/2 in T. gondii-infected ARPE-19 cells. Bevacizumab treatment or VEGF siRNA transfection significantly inhibited the proliferation of T. gondii tachyzoites in the host cell, dose-dependently, but not invasion of parasites. VEGF-receptor 2 (VEGF-R2) antagonist, SU5416, attenuated VEGF production and tachyzoite proliferation in T. gondii-infected ARPE-19 cells in a dose-dependent manner. Collectively, T. gondii prominently induces VEGF production in ARPE-19 cells, and VEGF and AKT/ERK1/2 signaling pathways mutually regulate each other in T. gondii-infected ARPE-19 cells, but not p38 MAPK and JNK1/2 signaling pathways. VEGF and VEGF-R2 control the parasite proliferation in T. gondii-infected ARPE-19 cells. From this study, we revealed the putative mechanisms for VEGF induction as well as the existence of positive feedback between VEGF and PI3K/MAPK signaling pathways in T. gondii-infected retinal pigment epithelium. |
doi_str_mv | 10.3389/fcimb.2020.00184 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7216739</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_842a30f5b4e3419f851ad28cd6eff40e</doaj_id><sourcerecordid>2405304158</sourcerecordid><originalsourceid>FETCH-LOGICAL-c462t-b7007a8f32aa4b6883992c017d7a33938b24d743559dc20bff6ee75cf707f1cd3</originalsourceid><addsrcrecordid>eNqNks1v0zAYxiMEYlPZnRPyEQm19WfiXJCqqBvVJjGVwtVy_JF6Su0SJ4z-AfzfuOmothu-2LKf5-fXr58se4_gjBBezq1yu3qGIYYzCBGnr7JLjAmb4pLz18_WF9lVjA8wjQJiXpK32QXBlGDI8GX258fy5hrcd0EPqnfBg1UEa9MMreyNBvUB9FsDFreb-XJ9i-YYfHONl63zDbiX_fZRHoD0GlTB911o46hOsNZZ08mRFyzYhN9h38q4k6AJXjsHnAeL9f1yikpQmbaN77I3VrbRXD3Nk-z79XJTfZnefb1ZVYu7qaI57qd1kd4guSVYSlrnnJOyxAqiQheSkJLwGlNdUMJYqRWGtbW5MQVTtoCFRUqTSbY6cXWQD2LfuZ3sDiJIJ8aN0DVCdr1TrRGcYkmgZTU1hKLScoakxlzp3FhLoUmszyfWfqh3RiuTWiDbF9CXJ95tRRN-iQKjvEjVTrKPT4Au_BxM7MXORZXaIb0JQxSYQkYgRYwnKTxJVRdi7Iw9X4OgOIZBjGEQxzCIMQzJ8uF5eWfDv69PAn4SPJo62Kic8cqcZSktjOSQQ3YMDqpcP35nFQbfJ-un_7eSvwGs0Lk</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2405304158</pqid></control><display><type>article</type><title>VEGF Production Is Regulated by the AKT/ERK1/2 Signaling Pathway and Controls the Proliferation of Toxoplasma gondii in ARPE-19 Cells</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /></source><source>PubMed Central</source><creator>Quan, Juan-Hua ; Ismail, Hassan Ahmed Hassan Ahmed ; Cha, Guang-Ho ; Jo, Young-Joon ; Gao, Fei Fei ; Choi, In-Wook ; Chu, Jia-Qi ; Yuk, Jae-Min ; Lee, Young-Ha</creator><creatorcontrib>Quan, Juan-Hua ; Ismail, Hassan Ahmed Hassan Ahmed ; Cha, Guang-Ho ; Jo, Young-Joon ; Gao, Fei Fei ; Choi, In-Wook ; Chu, Jia-Qi ; Yuk, Jae-Min ; Lee, Young-Ha</creatorcontrib><description>The retina is the primary site of Toxoplasma gondii infection in the eye, and choroidal neovascularization in ocular toxoplasmosis is one of the most important causes of visual impairment. Vascular endothelial growth factor (VEGF) is one of the key regulators of blood vessel development, however, little is known about the mechanisms of T. gondii-induced VEGF production in ocular toxoplasmosis. Here, we investigate the effect of T. gondii on VEGF production regulation in human retinal pigment epithelium ARPE-19 cells and attempted to unveil the underlying mechanism of this event by focusing on the interaction between parasite and the selected host intracellular signaling pathways. T. gondii infection increased the expression of VEGF mRNA and protein in ARPE-19 cells in parasite burden- and infection time-dependent manner. The proportional increase of VEGF upstream regulators, HIF-1 alpha and HO-1, was also observed. T. gondii induced the activation of host p-AKT, p-ERK1/2, and p-p38 MAPK in ARPE-19 cells in a parasite-burden dependent manner. However, VEGF expression decreased after the pre-treatment with PI3K inhibitors (LY294002 and GDC-0941), ERK1/2 inhibitor (PD098059), and p38 MAPK inhibitor (SB203580), but not JNK inhibitor (SP600125), in a dose-dependent manner. The anti-VEGF agent bevacizumab or VEGF siRNA transfection prominently inhibited the activation of p-AKT and p-ERK1/2, but not p-p38 MAPK and JNK1/2 in T. gondii-infected ARPE-19 cells. Bevacizumab treatment or VEGF siRNA transfection significantly inhibited the proliferation of T. gondii tachyzoites in the host cell, dose-dependently, but not invasion of parasites. VEGF-receptor 2 (VEGF-R2) antagonist, SU5416, attenuated VEGF production and tachyzoite proliferation in T. gondii-infected ARPE-19 cells in a dose-dependent manner. Collectively, T. gondii prominently induces VEGF production in ARPE-19 cells, and VEGF and AKT/ERK1/2 signaling pathways mutually regulate each other in T. gondii-infected ARPE-19 cells, but not p38 MAPK and JNK1/2 signaling pathways. VEGF and VEGF-R2 control the parasite proliferation in T. gondii-infected ARPE-19 cells. From this study, we revealed the putative mechanisms for VEGF induction as well as the existence of positive feedback between VEGF and PI3K/MAPK signaling pathways in T. gondii-infected retinal pigment epithelium.</description><identifier>ISSN: 2235-2988</identifier><identifier>EISSN: 2235-2988</identifier><identifier>DOI: 10.3389/fcimb.2020.00184</identifier><identifier>PMID: 32432052</identifier><language>eng</language><publisher>LAUSANNE: Frontiers Media Sa</publisher><subject>Cellular and Infection Microbiology ; Immunology ; Life Sciences & Biomedicine ; Microbiology ; ocular toxoplasmosis ; PI3K/MAPK signaling pathways ; retinal pigment epithelium ; Science & Technology ; Toxoplasma gondii proliferation ; vascular endothelial growth factor</subject><ispartof>Frontiers in cellular and infection microbiology, 2020-04, Vol.10, p.184-184, Article 184</ispartof><rights>Copyright © 2020 Quan, Ismail, Cha, Jo, Gao, Choi, Chu, Yuk and Lee.</rights><rights>Copyright © 2020 Quan, Ismail, Cha, Jo, Gao, Choi, Chu, Yuk and Lee. 2020 Quan, Ismail, Cha, Jo, Gao, Choi, Chu, Yuk and Lee</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>7</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000536080500001</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c462t-b7007a8f32aa4b6883992c017d7a33938b24d743559dc20bff6ee75cf707f1cd3</citedby><cites>FETCH-LOGICAL-c462t-b7007a8f32aa4b6883992c017d7a33938b24d743559dc20bff6ee75cf707f1cd3</cites><orcidid>0000-0001-6554-9596</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216739/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216739/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,865,886,2103,2115,27929,27930,28253,53796,53798</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32432052$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Quan, Juan-Hua</creatorcontrib><creatorcontrib>Ismail, Hassan Ahmed Hassan Ahmed</creatorcontrib><creatorcontrib>Cha, Guang-Ho</creatorcontrib><creatorcontrib>Jo, Young-Joon</creatorcontrib><creatorcontrib>Gao, Fei Fei</creatorcontrib><creatorcontrib>Choi, In-Wook</creatorcontrib><creatorcontrib>Chu, Jia-Qi</creatorcontrib><creatorcontrib>Yuk, Jae-Min</creatorcontrib><creatorcontrib>Lee, Young-Ha</creatorcontrib><title>VEGF Production Is Regulated by the AKT/ERK1/2 Signaling Pathway and Controls the Proliferation of Toxoplasma gondii in ARPE-19 Cells</title><title>Frontiers in cellular and infection microbiology</title><addtitle>FRONT CELL INFECT MI</addtitle><addtitle>Front Cell Infect Microbiol</addtitle><description>The retina is the primary site of Toxoplasma gondii infection in the eye, and choroidal neovascularization in ocular toxoplasmosis is one of the most important causes of visual impairment. Vascular endothelial growth factor (VEGF) is one of the key regulators of blood vessel development, however, little is known about the mechanisms of T. gondii-induced VEGF production in ocular toxoplasmosis. Here, we investigate the effect of T. gondii on VEGF production regulation in human retinal pigment epithelium ARPE-19 cells and attempted to unveil the underlying mechanism of this event by focusing on the interaction between parasite and the selected host intracellular signaling pathways. T. gondii infection increased the expression of VEGF mRNA and protein in ARPE-19 cells in parasite burden- and infection time-dependent manner. The proportional increase of VEGF upstream regulators, HIF-1 alpha and HO-1, was also observed. T. gondii induced the activation of host p-AKT, p-ERK1/2, and p-p38 MAPK in ARPE-19 cells in a parasite-burden dependent manner. However, VEGF expression decreased after the pre-treatment with PI3K inhibitors (LY294002 and GDC-0941), ERK1/2 inhibitor (PD098059), and p38 MAPK inhibitor (SB203580), but not JNK inhibitor (SP600125), in a dose-dependent manner. The anti-VEGF agent bevacizumab or VEGF siRNA transfection prominently inhibited the activation of p-AKT and p-ERK1/2, but not p-p38 MAPK and JNK1/2 in T. gondii-infected ARPE-19 cells. Bevacizumab treatment or VEGF siRNA transfection significantly inhibited the proliferation of T. gondii tachyzoites in the host cell, dose-dependently, but not invasion of parasites. VEGF-receptor 2 (VEGF-R2) antagonist, SU5416, attenuated VEGF production and tachyzoite proliferation in T. gondii-infected ARPE-19 cells in a dose-dependent manner. Collectively, T. gondii prominently induces VEGF production in ARPE-19 cells, and VEGF and AKT/ERK1/2 signaling pathways mutually regulate each other in T. gondii-infected ARPE-19 cells, but not p38 MAPK and JNK1/2 signaling pathways. VEGF and VEGF-R2 control the parasite proliferation in T. gondii-infected ARPE-19 cells. From this study, we revealed the putative mechanisms for VEGF induction as well as the existence of positive feedback between VEGF and PI3K/MAPK signaling pathways in T. gondii-infected retinal pigment epithelium.</description><subject>Cellular and Infection Microbiology</subject><subject>Immunology</subject><subject>Life Sciences & Biomedicine</subject><subject>Microbiology</subject><subject>ocular toxoplasmosis</subject><subject>PI3K/MAPK signaling pathways</subject><subject>retinal pigment epithelium</subject><subject>Science & Technology</subject><subject>Toxoplasma gondii proliferation</subject><subject>vascular endothelial growth factor</subject><issn>2235-2988</issn><issn>2235-2988</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>AOWDO</sourceid><sourceid>DOA</sourceid><recordid>eNqNks1v0zAYxiMEYlPZnRPyEQm19WfiXJCqqBvVJjGVwtVy_JF6Su0SJ4z-AfzfuOmothu-2LKf5-fXr58se4_gjBBezq1yu3qGIYYzCBGnr7JLjAmb4pLz18_WF9lVjA8wjQJiXpK32QXBlGDI8GX258fy5hrcd0EPqnfBg1UEa9MMreyNBvUB9FsDFreb-XJ9i-YYfHONl63zDbiX_fZRHoD0GlTB911o46hOsNZZ08mRFyzYhN9h38q4k6AJXjsHnAeL9f1yikpQmbaN77I3VrbRXD3Nk-z79XJTfZnefb1ZVYu7qaI57qd1kd4guSVYSlrnnJOyxAqiQheSkJLwGlNdUMJYqRWGtbW5MQVTtoCFRUqTSbY6cXWQD2LfuZ3sDiJIJ8aN0DVCdr1TrRGcYkmgZTU1hKLScoakxlzp3FhLoUmszyfWfqh3RiuTWiDbF9CXJ95tRRN-iQKjvEjVTrKPT4Au_BxM7MXORZXaIb0JQxSYQkYgRYwnKTxJVRdi7Iw9X4OgOIZBjGEQxzCIMQzJ8uF5eWfDv69PAn4SPJo62Kic8cqcZSktjOSQQ3YMDqpcP35nFQbfJ-un_7eSvwGs0Lk</recordid><startdate>20200428</startdate><enddate>20200428</enddate><creator>Quan, Juan-Hua</creator><creator>Ismail, Hassan Ahmed Hassan Ahmed</creator><creator>Cha, Guang-Ho</creator><creator>Jo, Young-Joon</creator><creator>Gao, Fei Fei</creator><creator>Choi, In-Wook</creator><creator>Chu, Jia-Qi</creator><creator>Yuk, Jae-Min</creator><creator>Lee, Young-Ha</creator><general>Frontiers Media Sa</general><general>Frontiers Media S.A</general><scope>AOWDO</scope><scope>BLEPL</scope><scope>DTL</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-6554-9596</orcidid></search><sort><creationdate>20200428</creationdate><title>VEGF Production Is Regulated by the AKT/ERK1/2 Signaling Pathway and Controls the Proliferation of Toxoplasma gondii in ARPE-19 Cells</title><author>Quan, Juan-Hua ; Ismail, Hassan Ahmed Hassan Ahmed ; Cha, Guang-Ho ; Jo, Young-Joon ; Gao, Fei Fei ; Choi, In-Wook ; Chu, Jia-Qi ; Yuk, Jae-Min ; Lee, Young-Ha</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c462t-b7007a8f32aa4b6883992c017d7a33938b24d743559dc20bff6ee75cf707f1cd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Cellular and Infection Microbiology</topic><topic>Immunology</topic><topic>Life Sciences & Biomedicine</topic><topic>Microbiology</topic><topic>ocular toxoplasmosis</topic><topic>PI3K/MAPK signaling pathways</topic><topic>retinal pigment epithelium</topic><topic>Science & Technology</topic><topic>Toxoplasma gondii proliferation</topic><topic>vascular endothelial growth factor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Quan, Juan-Hua</creatorcontrib><creatorcontrib>Ismail, Hassan Ahmed Hassan Ahmed</creatorcontrib><creatorcontrib>Cha, Guang-Ho</creatorcontrib><creatorcontrib>Jo, Young-Joon</creatorcontrib><creatorcontrib>Gao, Fei Fei</creatorcontrib><creatorcontrib>Choi, In-Wook</creatorcontrib><creatorcontrib>Chu, Jia-Qi</creatorcontrib><creatorcontrib>Yuk, Jae-Min</creatorcontrib><creatorcontrib>Lee, Young-Ha</creatorcontrib><collection>Web of Science - Science Citation Index Expanded - 2020</collection><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in cellular and infection microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Quan, Juan-Hua</au><au>Ismail, Hassan Ahmed Hassan Ahmed</au><au>Cha, Guang-Ho</au><au>Jo, Young-Joon</au><au>Gao, Fei Fei</au><au>Choi, In-Wook</au><au>Chu, Jia-Qi</au><au>Yuk, Jae-Min</au><au>Lee, Young-Ha</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>VEGF Production Is Regulated by the AKT/ERK1/2 Signaling Pathway and Controls the Proliferation of Toxoplasma gondii in ARPE-19 Cells</atitle><jtitle>Frontiers in cellular and infection microbiology</jtitle><stitle>FRONT CELL INFECT MI</stitle><addtitle>Front Cell Infect Microbiol</addtitle><date>2020-04-28</date><risdate>2020</risdate><volume>10</volume><spage>184</spage><epage>184</epage><pages>184-184</pages><artnum>184</artnum><issn>2235-2988</issn><eissn>2235-2988</eissn><abstract>The retina is the primary site of Toxoplasma gondii infection in the eye, and choroidal neovascularization in ocular toxoplasmosis is one of the most important causes of visual impairment. Vascular endothelial growth factor (VEGF) is one of the key regulators of blood vessel development, however, little is known about the mechanisms of T. gondii-induced VEGF production in ocular toxoplasmosis. Here, we investigate the effect of T. gondii on VEGF production regulation in human retinal pigment epithelium ARPE-19 cells and attempted to unveil the underlying mechanism of this event by focusing on the interaction between parasite and the selected host intracellular signaling pathways. T. gondii infection increased the expression of VEGF mRNA and protein in ARPE-19 cells in parasite burden- and infection time-dependent manner. The proportional increase of VEGF upstream regulators, HIF-1 alpha and HO-1, was also observed. T. gondii induced the activation of host p-AKT, p-ERK1/2, and p-p38 MAPK in ARPE-19 cells in a parasite-burden dependent manner. However, VEGF expression decreased after the pre-treatment with PI3K inhibitors (LY294002 and GDC-0941), ERK1/2 inhibitor (PD098059), and p38 MAPK inhibitor (SB203580), but not JNK inhibitor (SP600125), in a dose-dependent manner. The anti-VEGF agent bevacizumab or VEGF siRNA transfection prominently inhibited the activation of p-AKT and p-ERK1/2, but not p-p38 MAPK and JNK1/2 in T. gondii-infected ARPE-19 cells. Bevacizumab treatment or VEGF siRNA transfection significantly inhibited the proliferation of T. gondii tachyzoites in the host cell, dose-dependently, but not invasion of parasites. VEGF-receptor 2 (VEGF-R2) antagonist, SU5416, attenuated VEGF production and tachyzoite proliferation in T. gondii-infected ARPE-19 cells in a dose-dependent manner. Collectively, T. gondii prominently induces VEGF production in ARPE-19 cells, and VEGF and AKT/ERK1/2 signaling pathways mutually regulate each other in T. gondii-infected ARPE-19 cells, but not p38 MAPK and JNK1/2 signaling pathways. VEGF and VEGF-R2 control the parasite proliferation in T. gondii-infected ARPE-19 cells. From this study, we revealed the putative mechanisms for VEGF induction as well as the existence of positive feedback between VEGF and PI3K/MAPK signaling pathways in T. gondii-infected retinal pigment epithelium.</abstract><cop>LAUSANNE</cop><pub>Frontiers Media Sa</pub><pmid>32432052</pmid><doi>10.3389/fcimb.2020.00184</doi><tpages>18</tpages><orcidid>https://orcid.org/0000-0001-6554-9596</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2235-2988 |
ispartof | Frontiers in cellular and infection microbiology, 2020-04, Vol.10, p.184-184, Article 184 |
issn | 2235-2988 2235-2988 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7216739 |
source | DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" />; PubMed Central |
subjects | Cellular and Infection Microbiology Immunology Life Sciences & Biomedicine Microbiology ocular toxoplasmosis PI3K/MAPK signaling pathways retinal pigment epithelium Science & Technology Toxoplasma gondii proliferation vascular endothelial growth factor |
title | VEGF Production Is Regulated by the AKT/ERK1/2 Signaling Pathway and Controls the Proliferation of Toxoplasma gondii in ARPE-19 Cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T20%3A24%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=VEGF%20Production%20Is%20Regulated%20by%20the%20AKT/ERK1/2%20Signaling%20Pathway%20and%20Controls%20the%20Proliferation%20of%20Toxoplasma%20gondii%20in%20ARPE-19%20Cells&rft.jtitle=Frontiers%20in%20cellular%20and%20infection%20microbiology&rft.au=Quan,%20Juan-Hua&rft.date=2020-04-28&rft.volume=10&rft.spage=184&rft.epage=184&rft.pages=184-184&rft.artnum=184&rft.issn=2235-2988&rft.eissn=2235-2988&rft_id=info:doi/10.3389/fcimb.2020.00184&rft_dat=%3Cproquest_pubme%3E2405304158%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2405304158&rft_id=info:pmid/32432052&rft_doaj_id=oai_doaj_org_article_842a30f5b4e3419f851ad28cd6eff40e&rfr_iscdi=true |